Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

233
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
233
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

207
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
207
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

455
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
455
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

163
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
163
Survival Curves01:18

Survival Curves

229
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
229
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

309
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
309

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How should covariates be handled in randomized trials? Empirical evidence from 50 trials and recommendations for practice.

Journal of clinical epidemiology·2026
Same author

A quantitative framework to assess the potential of earlier cancer detection to improve cancer survival.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

A Bayesian phase I/II platform design with survival efficacy endpoint for dose optimization.

Statistical methods in medical research·2026
Same author

Histotripsy dose impacts tumor cellular damage and treatment outcomes in a preclinical model of hepatocellular carcinoma.

Scientific reports·2026
Same author

Gemcitabine plus nivolumab with carboplatin or oxaliplatin in cisplatin-ineligible patients with metastatic urothelial carcinoma: a randomized phase II trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects Model.

Pharmaceutical statistics·2026

Related Experiment Video

Updated: Aug 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Studentized permutation method for comparing two restricted mean survival times with small sample from randomized

Marc Ditzhaus1,2, Menggang Yu3, Jin Xu4

  • 1Department of Statistics, TU Dortmund University, Dortmund, Germany.

Statistics in Medicine
|April 18, 2023
PubMed
Summary

The proportional hazard assumption is often invalid in cancer trials. Restricted mean survival time (RMST) offers a model-free alternative, and a new studentized permutation test improves analysis for small, unbalanced groups.

Keywords:
hazard ratiopermutation methodsrestricted mean survival timesurvival analysistime-to-event outcomes

More Related Videos

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Related Experiment Videos

Last Updated: Aug 2, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

8.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Area of Science:

  • Biostatistics
  • Clinical Trial Analysis
  • Survival Analysis

Background:

  • The proportional hazard assumption in survival analysis is frequently violated in cancer immunotherapy trials, limiting the utility of hazard ratios.
  • Restricted Mean Survival Time (RMST) is a robust, model-free alternative for analyzing time-to-event data, offering intuitive interpretation.
  • Existing permutation tests for RMST have limitations, including a need for exchangeable data and inability to provide confidence intervals.

Purpose of the Study:

  • To address limitations of existing permutation tests for RMST.
  • To propose a novel studentized permutation test and associated confidence intervals for RMST.
  • To improve the statistical analysis of time-to-event data in clinical trials, particularly in challenging scenarios.

Main Methods:

  • Development of a studentized permutation test for comparing RMST between groups.
  • Construction of permutation-based confidence intervals for RMST.
  • Extensive simulation studies to evaluate the performance of the proposed methods.

Main Results:

  • The proposed studentized permutation test demonstrates improved performance, especially with small sample sizes and unbalanced groups, compared to existing methods.
  • Permutation-based confidence intervals provide valid and informative estimates.
  • The method shows advantages in simulations, maintaining appropriate Type-I error rates.

Conclusions:

  • The studentized permutation test and confidence intervals offer a valuable, robust approach for analyzing RMST in survival data.
  • These methods overcome limitations of classical permutation tests, enhancing applicability in real-world clinical trial settings.
  • The approach is illustrated with a lung cancer clinical trial example, demonstrating practical utility.